Back

planify

pre-IPO shares, ESOP... • 5d

PharmEasy Turnaround in Focus as Docon Sells 10% Stake in Thyrocare for ₹668 Crore PharmEasy has been in the spotlight recently as it works toward stabilizing its business and improving margins after a challenging period of aggressive expansion and promotional spending. The recent move by Docon selling its 10% stake in Thyrocare for ₹668 crore signals shifting investor confidence in related healthcare assets, and it also highlights broader restructuring activity within the sector. As PharmEasy refocuses on profitability and operational efficiency, analysts and investors are watching closely for signs of improved unit economics and sustainable growth. Based on current trends and future earnings expectations, a target share price range for PharmEasy over the next 12–18 months could be ₹150–₹220, assuming continued margin improvement and market sentiment recovery. This target reflects optimism around a potential turnaround while balancing existing risks tied to profitability and competitive pressures.

Reply

More like this

Recommendations from Medial

Image Description

mg

mysterious guy • 11m

Jio Financial to acquire SBI stake in Jio Payments Bank for Rs 104.5 crore.

1 Reply
9
Image Description

Somraj

 • 

Finicate • 1y

Anil agarwal, founder of Vedanta, bought 45% stake of Hindustan Zinc for ₹769 Crore in 2002. Today it's valuation is ₹67,000 crore

1 Reply
1
9

Mahendra Lochhab

Content creator • 1y

BLACKSTONE PLANS TO SUBMIT BID WORTH RS 40,000 CRORE TO ACQUIRE 51% STAKE IN HALDIRAM'S: REPORTS

Reply
5
Image Description

Account Deleted

Hey I am on Medial • 12m

MobiKwik Acquires 3.39% Stake in Blostem Fintech One MobiKwik Systems is acquiring a 3.39% stake in Blostem Fintech for Rs 1.49 crore as part of the second tranche of a share subscription agreement. Earlier, MobiKwik invested Rs 1.5 crore in March 2

See More
1 Reply
1
14
Image Description
Image Description

Account Deleted

Hey I am on Medial • 1y

PharmEasy's Shocking Valuation Drop: $5.6B to $456M! • Once valued at $5.6 billion, PharmEasy is now worth only about $456 million. • This major fall in valuation is because one of PharmEasy's investors, Janus Henderson Investors, indicated in a r

See More
8 Replies
1
8
Image Description

Account Deleted

Hey I am on Medial • 1y

𝗡𝘆𝗸𝗮𝗮 𝗜𝘀 𝗗𝗼𝗺𝗶𝗻𝗮𝘁𝗶𝗻𝗴 𝗜𝗻𝗱𝗶𝗮’𝘀 𝗕𝗲𝗮𝘂𝘁𝘆 𝗠𝗮𝗿𝗸𝗲𝘁! • In Q3 FY25, Nykaa reported a profit of ₹26 crore and revenue of ₹2267 crore, marking a 27% increase compared to Q3 FY24. • The beauty segment contributed 90% of the re

See More
2 Replies
1
7

financialnews

Founder And CEO Of F... • 1y

-Tata Steel; target of Rs 160: Motilal OswalMotilal Oswal recommended Neutral rating on Tata Steel with a target price of Rs 160 in its research report dated November 07, 2024. -Gujarat State Petronet; target of Rs 415 Motilal Oswal Motilal Oswal r

See More
Reply
4
Image Description

Tushar Aher Patil

Trying to do better • 1y

Ritesh Agarwal-led hospitality giant OYO recorded a net profit of Rs 158 crore and revenue of Rs 1,578 crore in Q2 FY25, PTI reported. This marks a significant turnaround, as the company had posted a net loss of Rs 50 crore during the same period la

See More
1 Reply
4
Image Description
Image Description

Mahendra Lochhab

Content creator • 1y

Snacks maker Haldiram Bhujiwala has raised Rs 235 crore from Pantomath's Bharat Value Fund (BVF) in lieu of a minority stake through private placement.

2 Replies
14
Image Description
Image Description

BigLoot IN

BigLoot.in - Where S... • 1y

🚴‍♂️ SWIGGY Swiggy Instamart has partnered with PharmEasy to deliver medicines in just 10 minutes across India! 🕑💊 Stay healthy and get your medications delivered fast. #SwiggyInstamart #MedicineDelivery #10MinuteDelivery #PharmEasy #FastDeliver

See More
2 Replies
5

Download the medial app to read full posts, comements and news.